SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-010641
Filing Date
2018-03-08
Accepted
2018-03-08 11:35:11
Documents
1
Period of Report
2018-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 16085
  Complete submission text file 0001127602-18-010641.txt   17388
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Issuer) CIK: 0001681689 (see all company filings)

IRS No.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Celona Lucia (Reporting) CIK: 0001692362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37859 | Film No.: 18675589